Evidence map›Paper›PMID 36453977›Full record

ArticleEuropean journal of clinical investigation2023

Potential of high-titre IgA convalescent plasma to improve survival and symptoms in COVID-19 patients.

Agnieszka Kuś, Szymon Wieczorek, Jarosław Dybko, Małgorzata Szymczyk-Nużka, Aleksandra Butrym, Sebastian Makuch, Grzegorz Mazur, Siddarth Agrawal

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Agnieszka KuśDepartment and Clinic of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland.
Szymon WieczorekDepartment and Clinic of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland.
Jarosław DybkoDepartment of Hematology and Cellular Transplantation, Lower Silesian Oncology Center, Wroclaw, Poland.
Małgorzata Szymczyk-NużkaRegional Centre of Transfusion Medicine and Blood Bank (RCTMBB-W), Wroclaw, Poland.
Aleksandra ButrymDepartment of Cancer Prevention and Therapy, Wroclaw Medical University, Wroclaw, Poland.
Sebastian MakuchDepartment of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland.
Grzegorz MazurDepartment and Clinic of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland.
Siddarth AgrawalDepartment and Clinic of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology, Wroclaw Medical University, Wroclaw, Poland.ORCID https://orcid.org/0000-0003-1118-5090

Funding

Medical Research Agency in Poland 2020.ABM.COVID19.0005
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, NeutralizingAntibodies, ViralCOVID-19 SerotherapyHumansImmunization, PassiveImmunoglobulin ASARS-CoV-2Treatment OutcomeAntibodies, NeutralizingAntibodies, ViralImmunoglobulin Aantibodiesconvalescent plasmaCOVID-19IgAtransfusion

Identifiers

PMID36453977
PMCPMC9877863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.